Saturday 17 October 2026
Export LIVN’s income statement to Excel — free account
LivaNova PLC
LIVN Healthcare Medical Devices
LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
77.60
0.90
−1.15%
Follow LIVN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 6 | 4 | 5 |
+8 more TTM periods Free account |
| 15.40% | 9.54% | (19.24%) | (17.63%) | ||
| 7.33% | 4.22% | (9.49%) | (8.56%) | ||
ROIC |
10.63% | 12.52% | 13.24% | 12.81% | |
Return on Tangible Assets |
31.88% | 21.12% | (45.22%) | (44.56%) | |
Average Days of Receivables |
57.37 | 58.38 | 56.80 | 57.25 | |
Free Cash Flow per Share |
2.83 | 3.08 | 3.31 | 3.51 | |
Free Cash Flow |
155.59 | 168.32 | 180.57 | 191.52 | |
Capital Expenditures |
(93.67) | (77.27) | (73.77) | (59.13) | |
| Other line items | |||||
Cash ROIC |
7.29% | 8.26% | 8.16% | 8.56% | |
Accounts Receivable Turnover |
6.52 | 6.65 | 6.79 | 6.60 | |
Accounts Payable Turnover |
4.93 | 4.99 | 5.37 | 5.28 | |
Inventory Turnover |
2.78 | 2.92 | 2.87 | 2.66 | |
Average Days of Payables |
80.38 | 77.64 | 79.12 | 73.35 | |
Days of Inventory on Hand |
134.20 | 129.61 | 134.13 | 139.40 | |
Tax Rate |
0.76 | (0.12) | 0.10 | 0.13 | |
Research and Development Expense of Revenue |
14.48% | 14.41% | 13.38% | 13.12% | |
Selling, General and Administrative Expense of Revenue |
39.66% | 39.29% | 39.54% | 39.43% | |
Share Based Compensation of Revenue |
3.02% | 2.57% | 2.61% | 2.51% | |
Interest Coverage |
5.43 | 4.55 | 4.05 | 3.41 | |
Operating CF/Net income |
1.32 | 2.29 | (1.05) | (1.15) | |
Depreciation/Fixed assets |
0.31 | 0.32 | 0.34 | 0.37 | |
Capex/Depreciation |
(1.10) | (0.93) | (0.89) | (0.73) | |
Revenue per Share |
26.77 | 26.21 | 25.45 | 24.69 | |
Operating CF per Share |
4.53 | 4.49 | 4.66 | 4.59 | |
Capex per Share |
(1.70) | (1.41) | (1.35) | (1.08) | |
Capex to Sales |
0.06 | 0.05 | 0.05 | 0.04 |
Columns are period end dates